ANDA 75875, held by Taro. Carbamazepine.
As of Nov 15, 2026, ANDA 75875 (Carbamazepine), held by Taro, was first approved by FDA on Dec 21, 2000, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 21, 2000 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carbamazepine100MG/5ML ยท suspension;oral | Carbamazepine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
